Within this retrospective study, 53 patients diagnosed with PC were enrolled to receive either PD-1 blockade combined with nab-paclitaxel plus gemcitabine or nab-paclitaxel plus gemcitabine alone. The gene discussed is PDCD1; the disease is pachyonychia congenita.